Organization
Institute of Liver Studies
2 abstracts
Abstract
Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC).Org: Institute of Liver Studies, Kinomica Limited,
Abstract
Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC).Org: King's College London, Kinomica Limited, King's College Hospital NHS Foundation, Institute of Liver Studies, King’s College Hospital, Institute of Liver Studies,